40 results
8-K
EX-1.1
IMVT
Immunovant Inc
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
.
“General Disclosure Package” means any Issuer General Use Free Writing Prospectuses issued at or prior to the Applicable Time, the most recent preliminary … not misleading. As of the Applicable Time, none of (A) the General Disclosure Package, (B) any individual Issuer Limited Use Free Writing Prospectus, when
8-K
EX-99.1
p0fx a5xh0ia09e
8 Dec 22
Regulation FD Disclosure
7:06am
8-K
EX-1.1
q73xp0dy
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm
8-K
EX-99.1
v6v3nz14q61ckxb3
7 Sep 22
Regulation FD Disclosure
6:39am
424B4
7y3ql nlo
3 Sep 20
Prospectus supplement with pricing info
12:00am
DRS
t265k21tcmukxg769
19 Aug 20
Draft registration statement
12:00am